fbpx ESAIC

CovidSurg Week

The ESAIC is delighted to support the NIHR Global Health Research Unit on Global Surgery in the SURG-Week study.

This is a large, international, observational study that aims to determine the optimal timing of surgery following SARS-CoV-2 infection and to assess key global surgical indicators. All hospitals worldwide can participate, including those that have not admitted SARS-CoV-2 infected patients. All ages, all surgical specialities, any operation, and any patient regardless of SARS-CoV-2 status may be included. CovidSurg Collaborative is a global collaborative exploring the impact of COVID-19 in surgical patients and services. 

 

2 main studies: CovidSurg Cohort study and CovidSurg-Cancer study are already in the closing phases as well as a modelling study 

 

CovidSurg Week

All hospitals. All specialities. All patients. One week of data collection. 

  • To determine the optimal timing of surgery following SARS-CoV-2 infection. 
  • Assess key global surgical indicators, such as postoperative mortality. 
  • All hospitals can participate in this studyincluding hospitals that have not admitted SARS-CoV-2 infected patients. 
  • All patients (from all specialities) undergoing a surgical procedure done in an operating theatre will be included (any SARS-CoV-2 status). 
  • All collaborators will be included as PubMed-citable co-authors on resulting publications. 

 

Primary aim: To determine the optimal timing for surgery following SARS-CoV-2 infection 

Secondary aim: Determine key global surgical indicators such as postoperative mortality rates 

 

Study Timeline

14th JulyStudy Lunch: Register your interest and seek study approvals 

1st SeptemberTeam registration and REDCap access: Register your team for a REDCap account

October Start of data collection: Your 7-day data collection period should start in October 

+7 days       30 days follow-up 

 

Collaborative Authorship: All collaborators recognised as PubMed citable co-authors in any publications resulting from these studies under ‘CovidSurg Collaborative.’